These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7045224)

  • 1. Immunity to herpes simplex virus type 2. IV. Impaired lymphokine production during recrudescence correlates with an imbalance in T lymphocyte subsets.
    Sheridan JF; Donnenberg AD; Aurelian L; Elpern DJ
    J Immunol; 1982 Jul; 129(1):326-31. PubMed ID: 7045224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
    Sheridan JF; Aurelian L
    Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactivation of herpes simplex virus is associated with production of a low molecular weight factor that inhibits lymphokine activity in vitro.
    Sheridan JF; Beck M; Smith CC; Aurelian L
    J Immunol; 1987 Feb; 138(4):1234-9. PubMed ID: 3027176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie S; Maingay J; Neill WA
    Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-mediated immune responses in patients with recurrent Herpes Simplex infections. II. Infection-associated deficiency of lymphokine production in patients with recurrent herpes labialis or herpes progenitalis.
    O'Reilly RJ; Chibbaro A; Anger E; Lopez C
    J Immunol; 1977 Mar; 118(3):1095-1102. PubMed ID: 191524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replication of herpes simplex virus in human T lymphocytes: characterization of the viral target cell.
    Braun RW; Teute HK; Kirchner H; Munk K
    J Immunol; 1984 Feb; 132(2):914-9. PubMed ID: 6317753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of leukocyte migration inhibition factor (LIF) and migration stimulation factor (MStF) by CD4+ and CD8+ human lymphocytes subsets and T-cell clones.
    Méndez-Samperio P; Jiménez-Zamudio L; Favila-Castillo L
    Rev Invest Clin; 1989; 41(2):107-15. PubMed ID: 2675234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human T cell production of migration inhibitory lymphokines by cytokines derived from human leukocyte dialysates.
    Gottlieb AA; Farmer JL; Matzura CT; Hester RB; Rosenberg JS
    J Immunol; 1984 Jan; 132(1):256-60. PubMed ID: 6361122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to herpes simplex virus type 2: cell-mediated immunity in latently infected guinea pigs.
    Donnenberg AD; Chaikof E; Aurelian L
    Infect Immun; 1980 Oct; 30(1):99-109. PubMed ID: 6254886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and humoral immunity in the pathogenesis of recurrent herpes viral infections in patients with lymphoma.
    Arvin AM; Pollard RB; Rasmussen LE; Merigan TC
    J Clin Invest; 1980 Apr; 65(4):869-78. PubMed ID: 6244336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular interactions in spontaneous or autologous cell-induced proliferative and lymphokine responses of human lymphocytes.
    Arvilommi H; Räsänen L
    Immunology; 1980 Aug; 40(4):695-700. PubMed ID: 6448804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological responses of patients with recurrent herpes genitalis.
    Sirianni MC; Bonomo R; Scarpati B; Soddu S; Panà A; Turbessi G; Cherchi M; Aiuti F
    Diagn Immunol; 1986; 4(6):294-8. PubMed ID: 3493109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum migration inhibitory activity and monoclonal antibody-defined T-cell phenotypes in patients with acute infectious mononucleosis.
    Bertotto A; Gentili F; Stagni G; Zucchetti P; Vaccaro R
    Microbiologica; 1983 Jul; 6(3):221-7. PubMed ID: 6226848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of T lymphocytes in autoimmune thyroid disease.
    Ahmann AJ; Burman KD
    Endocrinol Metab Clin North Am; 1987 Jun; 16(2):287-326. PubMed ID: 3319586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunity to herpes simplex virus type 2 (HSV-2). I. Development of virus-specific lymphoproliferative and leukocyte migration inhibition factor responses in HSV-2-infected guinea pigs.
    Donnenberg AD; Bell RB; Aurelian L
    Cell Immunol; 1980 Dec; 56(2):526-39. PubMed ID: 6258811
    [No Abstract]   [Full Text] [Related]  

  • 16. Leukocyte migration inhibitory factor in HSV infections.
    Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired natural killer cytotoxicity during recrudescence of recurrent herpes simplex virus type 1 infection.
    Kuo YC; Lin CY; Cheng SF; Lin CC; Liu WT
    Cancer Detect Prev Suppl; 1987; 1():51-5. PubMed ID: 3480065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-mediated immunity to cytomegalovirus (CMV) and herpes simplex virus (HSV) antigens in the acquired immune deficiency syndrome: interleukin-1 and interleukin-2 modify in vitro responses.
    Sheridan JF; Aurelian L; Donnenberg AD; Quinn TC
    J Clin Immunol; 1984 Jul; 4(4):304-11. PubMed ID: 6086703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-mediated immunity and immunosuppression in herpes simplex virus infection.
    Rinaldo CR; Torpey DJ
    Immunodeficiency; 1993; 5(1):33-90. PubMed ID: 8167747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
    Meyers-Elliott RH; Chitjian PA
    Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.